Clinical analysis of pulmonary cryptococcosis in non-HIV patients in south China.
نویسندگان
چکیده
AIMS The aim of this study was to investigate the clinical characteristics of pulmonary cryptococcosis occurring in non-HIV patients, and to develop early diagnosis of pulmonary cryptococcosis in immunocompetent cases as well. METHODS We retrospectively reviewed the clinical data of 41 non-HIV infected patients with pulmonary cryptococcosis who were admitted to the First Affiliated Hospital of Wenzhou Medical University from January 2006 to April 2014. RESULTS The study included a total of 41 patients (23 males and 18 females) with mean age of 47 years. 12.19% of patients had a history of direct exposure to pigeon droppings; 31.70% of the patients' working or living environments were potentially contaminated by fungal spores. Almost one-third of the patients involved into the study were asymptomatic. The most common clinical manifestations were cough, expectoration and hemoptysis. The most common radiological manifestation was single node or mass in lung, which was described as untypical. Of all cases, 11 patients were diagnosed by CT-guided percutaneous cutting needle biopsy (PCNB), 5 patients were diagnosed by operation, and Crytococcus spore was found in 7 patients' cerebrospinal fluid. 8 patients' blood Cryptococcus Neoformans capsular polysaccharide antigens latex agglutination tests were positive. 36 patients received antifungal therapy. 5 patients underwent surgical resection. During 6 to 24 months follow-up, 40 cases showed total recovery and 1 cases showed improvement. CONCLUSIONS Pulmonary cryptococcosis in non-HIV subjects might be related to fungus-contaminated environmental exposure. The great variations and protean manifestations of its clinical features often lead to misdiagnosis. Recognition and invasive examination of non-HIV infected patients' pulmonary cryptococcosis in the early stage may help with improvement of its diagnosis and prognosis.
منابع مشابه
Cryptococcosis and tuberculosis co-infection in mainland China
Dear Editor, Cryptococcosis is a fungal infection caused by members of the Cryptococcus neoformans/C. gattii species complex,1 which causes approximately one million infections among HIV-infected patients per year, with approximately 625 000 annual mortalities among HIV/AIDS-associated deaths worldwide.2 Tuberculosis (TB), which is currently the second leading cause of death from infectious dis...
متن کاملClinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis.
The aim of the present study was to investigate the clinical characteristics of pulmonary cryptococcosis patients in China, with analysis of immunocompetent and immunocompromised subjects. We performed a retrospective review of 76 patients diagnosed with tissue-confirmed pulmonary cryptococcosis at the Shanghai Pulmonary Hospital (Shanghai, China) during a 10-yr period (2001-2010). Of 76 patien...
متن کاملClinical features of pulmonary cryptococcosis in non-HIV patients in Japan.
OBJECTIVE To clarify the clinical features of pulmonary cryptococcosis in Japanese non-HIV population. METHODS Retrospective investigation of 151 pulmonary cryptococcosis cases between 1977 and 2012 was executed. The underlying disease (UDs), aggravating factors, radiological characteristics, and treatment were examined. RESULTS Sixty-seven patients (44.4%) had no UDs. The common UDs were d...
متن کاملPulmonary cryptococcosis in non-AIDS patients.
PURPOSE To clarify the clinical features and imaging characteristics of non-AIDS patients with pulmonary cryptococcosis. METHODS We retrospectively collected 15 HIV-negative patients with pathology-proved pulmonary cryptococcosis from Sep 1992 to Jan 2008. Their medical records and radiological data were reviewed and analyzed. RESULTS Only one patient was asymptomatic.Thirteen patients were...
متن کاملRelapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
A 35-year-old non-HIV patient developed pulmonary cryptococcosis after the initiation of infliximab. He recovered by fluconazole treatment and completed the therapy for a total of 6 months. However, he experienced a relapse 16 months later during retreatment with infliximab, revealing an interesting clinical course contradicting retreatment. This case also represents the first case of relapsed ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- International journal of clinical and experimental medicine
دوره 8 3 شماره
صفحات -
تاریخ انتشار 2015